MCMedicalCodingSoftware
HCPCSC1000–C9999

HCPCS COutpatient Prospective Payment System

Devices, drugs and new technology reported by hospital outpatient departments under OPPS. Largely irrelevant to a physician-office coder, and a common source of wrong-setting denials.

619 codes in the current CMS release, 383 of them still active.

236 terminated C codes (no longer billable, kept for old claims)
  • C1300Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval
  • C1834Pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software application
  • C1841Retinal prosthesis, includes all internal and external components
  • C1842Retinal prosthesis, includes all internal and external components; add-on to c1841
  • C1849Skin substitute, synthetic, resorbable, per square centimeter
  • C5271Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area
  • C5272Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
  • C5273Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
  • C5274Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
  • C5275Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area
  • C5276Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
  • C5277Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
  • C5278Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
  • C7558Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed
  • C8904Magnetic resonance imaging without contrast, breast; unilateral
  • C8907Magnetic resonance imaging without contrast, breast; bilateral
  • C9014Injection, cerliponase alfa, 1 mg
  • C9015Injection, c-1 esterase inhibitor (human), haegarda, 10 units
  • C9016Injection, triptorelin extended release, 3.75 mg
  • C9021Injection, obinutuzumab, 10 mg
  • C9022Injection, elosulfase alfa, 1mg
  • C9023Injection, testosterone undecanoate, 1 mg
  • C9024Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
  • C9025Injection, ramucirumab, 5 mg
  • C9026Injection, vedolizumab, 1 mg
  • C9027Injection, pembrolizumab, 1 mg
  • C9028Injection, inotuzumab ozogamicin, 0.1 mg
  • C9029Injection, guselkumab, 1 mg
  • C9030Injection, copanlisib, 1 mg
  • C9031Lutetium lu 177, dotatate, therapeutic, 1 mci
  • C9032Injection, voretigene neparvovec-rzyl, 1 billion vector genome
  • C9033Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
  • C9034Injection, dexamethasone 9%, intraocular, 1 mcg
  • C9035Injection, aripiprazole lauroxil (aristada initio), 1 mg
  • C9036Injection, patisiran, 0.1 mg
  • C9037Injection, risperidone (perseris), 0.5 mg
  • C9038Injection, mogamulizumab-kpkc, 1 mg
  • C9039Injection, plazomicin, 5 mg
  • C9040Injection, fremanezumab-vfrm, 1mg
  • C9041Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
  • C9042Injection, bendamustine hcl (belrapzo), 1 mg
  • C9043Injection, levoleucovorin, 1 mg
  • C9044Injection, cemiplimab-rwlc, 1 mg
  • C9045Injection, moxetumomab pasudotox-tdfk, 0.01 mg
  • C9048Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
  • C9049Injection, tagraxofusp-erzs, 10 mcg
  • C9050Injection, emapalumab-lzsg, 1 mg
  • C9051Injection, omadacycline, 1 mg
  • C9052Injection, ravulizumab-cwvz, 10 mg
  • C9053Injection, crizanlizumab-tmca, 1 mg
  • C9054Injection, lefamulin (xenleta), 1 mg
  • C9055Injection, brexanolone, 1mg
  • C9056Injection, givosiran, 0.5 mg
  • C9057Injection, cetirizine hydrochloride, 1 mg
  • C9058Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg
  • C9059Injection, meloxicam, 1 mg
  • C9060Fluoroestradiol f18, diagnostic, 1 mci
  • C9061Injection, teprotumumab-trbw, 10 mg
  • C9062Injection, daratumumab 10 mg and hyaluronidase-fihj
  • C9063Injection, eptinezumab-jjmr, 1 mg
  • C9064Mitomycin pyelocalyceal instillation, 1 mg
  • C9065Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg
  • C9066Injection, sacituzumab govitecan-hziy, 2.5 mg
  • C9068Copper cu-64, dotatate, diagnostic, 1 millicurie
  • C9069Injection, belantamab mafodontin-blmf, 0.5 mg
  • C9070Injection, tafasitamab-cxix, 2 mg
  • C9071Injection, viltolarsen, 10 mg
  • C9072Injection, immune globulin (asceniv), 500 mg
  • C9073Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
  • C9074Injection, lumasiran, 0.5 mg
  • C9075Injection, casimersen, 10 mg
  • C9076Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
  • C9077Injection, cabotegravir and rilpivirine, 2mg/3mg
  • C9078Injection, trilaciclib, 1 mg
  • C9079Injection, evinacumab-dgnb, 5 mg
  • C9080Injection, melphalan flufenamide hydrochloride, 1 mg
  • C9081Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
  • C9082Injection, dostarlimab-gxly, 100 mg
  • C9083Injection, amivantamab-vmjw, 10 mg
  • C9084Injection, loncastuximab tesirine-lpyl, 0.1 mg
  • C9085Injection, avalglucosidase alfa-ngpt, 4 mg
  • C9086Injection, anifrolumab-fnia, 1 mg
  • C9087Injection, cyclophosphamide, (auromedics), 10 mg
  • C9088Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
  • C9089Bupivacaine, collagen-matrix implant, 1 mg
  • C9090Injection, plasminogen, human-tvmh, 1 mg
  • C9091Injection, sirolimus protein-bound particles, 1 mg
  • C9092Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg
  • C9093Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
  • C9094Inj, sutimlimab-jome, 10 mg
  • C9095Inj, tebentafusp-tebn, 1 mcg
  • C9096Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
  • C9097Inj, faricimab-svoa, 0.1 mg
  • C9098Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
  • C9113Injection, pantoprazole sodium, per vial
  • C9121Injection, argatroban, per 5 mg
  • C9122Mometasone furoate sinus implant, 10 micrograms (sinuva)
  • C9132Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
  • C9133Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
  • C9134Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
  • C9135Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
  • C9136Injection, factor viii, fc fusion protein, (recombinant), per i.u.
  • C9137Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
  • C9138Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
  • C9139Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
  • C9140Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
  • C9141Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
  • C9142Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
  • C9145Injection, aprepitant, (aponvie), 1 mg
  • C9146Injection, mirvetuximab soravtansine-gynx, 1 mg
  • C9147Injection, tremelimumab-actl, 1 mg
  • C9148Injection, teclistamab-cqyv, 0.5 mg
  • C9149Injection, teplizumab-mzwv, 5 mcg
  • C9150Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
  • C9151Injection, pegcetacoplan, 1 mg
  • C9152Injection, aripiprazole, (abilify asimtufii), 1 mg
  • C9153Injection, amisulpride, 1 mg
  • C9154Injection, buprenorphine extended-release (brixadi), 1 mg
  • C9155Injection, epcoritamab-bysp, 0.16 mg
  • C9156Flotufolastat f 18, diagnostic, 1 millicurie
  • C9157Injection, tofersen, 1 mg
  • C9158Injection, risperidone, (uzedy), 1 mg
  • C9159Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity
  • C9160Injection, daxibotulinumtoxina-lanm, 1 unit
  • C9161Injection, aflibercept hd, 1 mg
  • C9162Injection, avacincaptad pegol, 0.1 mg
  • C9163Injection, talquetamab-tgvs, 0.25 mg
  • C9164Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
  • C9165Injection, elranatamab-bcmm, 1 mg
  • C9166Injection, secukinumab, intravenous, 1 mg
  • C9167Injection, adamts13, recombinant-krhn, 10 iu
  • C9168Injection, mirikizumab-mrkz, 1 mg
  • C9169Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
  • C9170Injection, tarlatamab-dlle, 1 mg
  • C9171Injection, pegulicianine, 1 mg
  • C9172Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
  • C9173Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
  • C9174Injection, datopotamab deruxtecan-dlnk, 1 mg
  • C9175Injection, treosulfan, 50 mg
  • C9248Injection, clevidipine butyrate, 1 mg
  • C9275Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
  • C9290Injection, bupivacaine liposome, 1 mg
  • C9300Injection, indigotindisulfonate sodium, 1 mg
  • C9301Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
  • C9302Injection, zanidatamab-hrii, 2 mg
  • C9303Injection, zolbetuximab-clzb, 1 mg
  • C9304Injection, marstacimab-hncq, 0.5 mg
  • C9305Injection, nipocalimab-aahu, 3 mg
  • C9306Injection, telisotuzumab vedotin-tllv, 1 mg
  • C9307Injection, linvoseltamab-gcpt, 1 mg
  • C9308Injection, carboplatin (avyxa), 1 mg
  • C9309Injection, onasemnogene abeparvovec-brve, per treatment
  • C9349Puraply, and puraply antimicrobial, any type, per square centimeter
  • C9407Iodine i-131 iobenguane, diagnostic, 1 millicurie
  • C9408Iodine i-131 iobenguane, therapeutic, 1 millicurie
  • C9441Injection, ferric carboxymaltose, 1 mg
  • C9442Injection, belinostat, 10 mg
  • C9443Injection, dalbavancin, 10 mg
  • C9444Injection, oritavancin, 10 mg
  • C9445Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units
  • C9446Injection, tedizolid phosphate, 1 mg
  • C9447Injection, phenylephrine and ketorolac, 4 ml vial
  • C9448Netupitant 300 mg and palonosetron 0.5 mg, oral
  • C9449Injection, blinatumomab, 1 mcg
  • C9450Injection, fluocinolone acetonide intravitreal implant, 0.01 mg
  • C9451Injection, peramivir, 1 mg
  • C9452Injection, ceftolozane 50 mg and tazobactam 25 mg
  • C9453Injection, nivolumab, 1 mg
  • C9454Injection, pasireotide long acting, 1 mg
  • C9455Injection, siltuximab, 10 mg
  • C9456Injection, isavuconazonium sulfate, 1 mg
  • C9457Injection, sulfur hexafluoride lipid microsphere, per ml
  • C9458Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
  • C9459Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
  • C9461Choline c 11, diagnostic, per study dose
  • C9463Injection, aprepitant, 1 mg
  • C9464Injection, rolapitant, 0.5 mg
  • C9465Hyaluronan or derivative, durolane, for intra-articular injection, per dose
  • C9466Injection, benralizumab, 1 mg
  • C9467Injection, rituximab and hyaluronidase, 10 mg
  • C9468Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.
  • C9469Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
  • C9470Injection, aripiprazole lauroxil, 1 mg
  • C9471Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
  • C9472Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)
  • C9473Injection, mepolizumab, 1 mg
  • C9474Injection, irinotecan liposome, 1 mg
  • C9475Injection, necitumumab, 1 mg
  • C9476Injection, daratumumab, 10 mg
  • C9477Injection, elotuzumab, 1 mg
  • C9478Injection, sebelipase alfa, 1 mg
  • C9479Instillation, ciprofloxacin otic suspension, 6 mg
  • C9480Injection, trabectedin, 0.1 mg
  • C9481Injection, reslizumab, 1 mg
  • C9483Injection, atezolizumab, 10 mg
  • C9484Injection, eteplirsen, 10 mg
  • C9485Injection, olaratumab, 10 mg
  • C9486Injection, granisetron extended release, 0.1 mg
  • C9487Ustekinumab, for intravenous injection, 1 mg
  • C9489Injection, nusinersen, 0.1 mg
  • C9490Injection, bezlotoxumab, 10 mg
  • C9491Injection, avelumab, 10 mg
  • C9492Injection, durvalumab, 10 mg
  • C9493Injection, edaravone, 1 mg
  • C9494Injection, ocrelizumab, 1 mg
  • C9497Loxapine, inhalation powder, 10 mg
  • C9724Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy
  • C9735Anoscopy; with directed submucosal injection(s), any substance
  • C9737Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)
  • C9741Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report
  • C9742Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed
  • C9743Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies)
  • C9744Ultrasound, abdominal, with contrast
  • C9745Nasal endoscopy, surgical; balloon dilation of eustachian tube
  • C9746Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed
  • C9747Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance
  • C9748Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy
  • C9749Repair of nasal vestibular lateral wall stenosis with implant(s)
  • C9750Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode)
  • C9751Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s)
  • C9752Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum
  • C9753Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)
  • C9754Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed)
  • C9755Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed
  • C9769Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts
  • C9770Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent
  • C9771Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral
  • C9784Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components
  • C9786Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report
  • C9787Gastric electrophysiology mapping with simultaneous patient symptom profiling
  • C9788Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examination
  • C9790Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance
  • C9794Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)
  • C9795Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions
  • C9800Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies
  • C9803Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
HCPCS Level II2026Q3-Jul· effective July 1, 2026